These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 38452721

  • 1. Propranolol monotherapy in angiosarcoma - A window-of-opportunity study (PropAngio).
    Embaby A, Heinhuis KM, IJzerman NS, Koenen AM, van der Kleij S, Hofland I, van Boven H, Sanders J, van der Graaf WTA, Haas RL, Huitema ADR, van Houdt WJ, Steeghs N.
    Eur J Cancer; 2024 May; 202():113974. PubMed ID: 38452721
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.
    Pasquier E, André N, Street J, Chougule A, Rekhi B, Ghosh J, Philip DSJ, Meurer M, MacKenzie KL, Kavallaris M, Banavali SD.
    EBioMedicine; 2016 Apr; 6():87-95. PubMed ID: 27211551
    [Abstract] [Full Text] [Related]

  • 4. Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.
    Stiles JM, Amaya C, Rains S, Diaz D, Pham R, Battiste J, Modiano JF, Kokta V, Boucheron LE, Mitchell DC, Bryan BA.
    PLoS One; 2013 Apr; 8(3):e60021. PubMed ID: 23555867
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade.
    Chow W, Amaya CN, Rains S, Chow M, Dickerson EB, Bryan BA.
    JAMA Dermatol; 2015 Nov; 151(11):1226-9. PubMed ID: 26375166
    [Abstract] [Full Text] [Related]

  • 7. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
    Montoya A, Amaya CN, Belmont A, Diab N, Trevino R, Villanueva G, Rains S, Sanchez LA, Badri N, Otoukesh S, Khammanivong A, Liss D, Baca ST, Aguilera RJ, Dickerson EB, Torabi A, Dwivedi AK, Abbas A, Chambers K, Bryan BA, Nahleh Z.
    Oncotarget; 2017 Jan 24; 8(4):6446-6460. PubMed ID: 28031536
    [Abstract] [Full Text] [Related]

  • 8. A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol).
    Oashi K, Shibata T, Namikawa K, Takahashi A, Yokota K, Nakano E, Teramoto Y, Tsutsumida A, Maeda T, Yamazaki N, Dermatologic Oncology Group of the Japan Clinical Oncology Group.
    BMC Cancer; 2020 Jul 13; 20(1):652. PubMed ID: 32660439
    [Abstract] [Full Text] [Related]

  • 9. Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.
    Kaempfen S, Neumann RP, Jost K, Schulzke SM.
    Cochrane Database Syst Rev; 2018 Mar 02; 3(3):CD011893. PubMed ID: 29499081
    [Abstract] [Full Text] [Related]

  • 10. Prognostic Value of Quantitative Parameters of 18F-FDG PET/CT for Patients With Angiosarcoma.
    Kato A, Nakamoto Y, Ishimori T, Saga T, Togashi K.
    AJR Am J Roentgenol; 2020 Mar 02; 214(3):649-657. PubMed ID: 31939696
    [Abstract] [Full Text] [Related]

  • 11. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
    Kang F, Ma W, Ma X, Shao Y, Yang W, Chen X, Li L, Wang J.
    J Nucl Med; 2014 Mar 02; 55(3):439-45. PubMed ID: 24504055
    [Abstract] [Full Text] [Related]

  • 12. Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.
    Ravi V, Subramaniam A, Zheng J, Amini B, Trinh VA, Joseph J, Mennel RG, Bishop AJ, Sturgis EM, Goepfert RP, Yalamanchili S, Botello G, Stephen B, Piha-Paul SA, Patel AB, Lazar AJ, Conley AP, Benjamin RS, Patel SR, Futreal PA, Somaiah N, Naing A.
    Cancer; 2022 Sep 15; 128(18):3383-3391. PubMed ID: 35792683
    [Abstract] [Full Text] [Related]

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Sep 15; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 14. Primary bilateral angiosarcoma of the breast treated with neoadjuvant chemotherapy combined with propranolol.
    Luczynska E, Rudnicki W, Kargol J, Szpor J, Hodorowicz-Zaniewska D, Wysocki PJ, Gorski M, Popiela TJ.
    Breast J; 2021 Oct 15; 27(10):781-786. PubMed ID: 34263505
    [Abstract] [Full Text] [Related]

  • 15. Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment.
    Galván DC, Ayyappan AP, Bryan BA.
    Oncoscience; 2018 Sep 15; 5(9-10):264-268. PubMed ID: 30460329
    [Abstract] [Full Text] [Related]

  • 16. Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity.
    Gandhi S, Pandey MR, Attwood K, Ji W, Witkiewicz AK, Knudsen ES, Allen C, Tario JD, Wallace PK, Cedeno CD, Levis M, Stack S, Funchain P, Drabick JJ, Bucsek MJ, Puzanov I, Mohammadpour H, Repasky EA, Ernstoff MS.
    Clin Cancer Res; 2021 Jan 01; 27(1):87-95. PubMed ID: 33127652
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic usefulness of clinical features and pretreatment 18F-FDG PET/CT metabolic parameters in patients with angiosarcoma.
    Chen D, Tang M, Lv S, Wang H, Du W, Zhao X, Lin L, Zhu Y, Wang G, Zhu H, Zhao K.
    Quant Imaging Med Surg; 2022 May 01; 12(5):2792-2804. PubMed ID: 35502366
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial.
    Jones RL, Ravi V, Brohl AS, Chawla S, Ganjoo KN, Italiano A, Attia S, Burgess MA, Thornton K, Cranmer LD, Cheang MCU, Liu L, Robertson L, Adams B, Theuer C, Maki RG.
    JAMA Oncol; 2022 May 01; 8(5):740-747. PubMed ID: 35357396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.